Timothy G. Call

11.3k total citations
221 papers, 5.8k citations indexed

About

Timothy G. Call is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Timothy G. Call has authored 221 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Genetics, 128 papers in Pathology and Forensic Medicine and 74 papers in Immunology. Recurrent topics in Timothy G. Call's work include Chronic Lymphocytic Leukemia Research (190 papers), Lymphoma Diagnosis and Treatment (122 papers) and Immunodeficiency and Autoimmune Disorders (65 papers). Timothy G. Call is often cited by papers focused on Chronic Lymphocytic Leukemia Research (190 papers), Lymphoma Diagnosis and Treatment (122 papers) and Immunodeficiency and Autoimmune Disorders (65 papers). Timothy G. Call collaborates with scholars based in United States, Belarus and Israel. Timothy G. Call's co-authors include Neil E. Kay, Tait D. Shanafelt, Clive S. Zent, Susan L. Slager, Susan M. Schwager, Diane F. Jelinek, Deborah A. Bowen, Curtis A. Hanson, Kari G. Rabe and James R. Cerhan and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Timothy G. Call

213 papers receiving 5.7k citations

Peers

Countries citing papers authored by Timothy G. Call

Since Specialization

Citations

This map shows the geographic impact of Timothy G. Call's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy G. Call with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy G. Call more than expected).

Fields of papers citing papers by Timothy G. Call

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy G. Call. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy G. Call. The network helps show where Timothy G. Call may publish in the future.

Co-authorship network of co-authors of Timothy G. Call

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy G. Call. A scholar is included among the top collaborators of Timothy G. Call based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy G. Call. Timothy G. Call is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection 2022 ·Leukemia & lymphoma ·(unknown), Neil E. Kay, Sameer A. Parikh, Kari G. Rabe, Timothy G. Call, José F. Leis, Wei Ding, Susan L. Slager, Jacob D. Soumerai, Lindsey E. Roeker, Anthony R. Mato, Andrew D. Zelenetz	2
2	Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis 2022 ·Leukemia ·Nicholas Boddicker, Sara J. Achenbach, Sameer A. Parikh, Geffen Kleinstern, Esteban Braggio, Aaron D. Norman, Kari G. Rabe, Celine M. Vachon, Connie Lesnick, Timothy G. Call, Janet E. Olson, James R. Cerhan, Neil E. Kay, Curtis A. Hanson, Tait D. Shanafelt, Susan L. Slager	3
3	Progression and survival of MBL: a screening study of 10 139 individuals 2022 ·Blood ·Susan L. Slager, Sameer A. Parikh, Sara J. Achenbach, Aaron D. Norman, Kari G. Rabe, Nicholas Boddicker, Janet E. Olson, Geffen Kleinstern, Connie Lesnick, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Tait D. Shanafelt	13
4	Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma 2021 ·International Journal of Cancer ·Mark Liebow, Melissa C. Larson, Carrie A. Thompson, Grzegorz S. Nowakowski, Timothy G. Call, William R. Macon, Neil E. Kay, Thomas M. Habermann, Susan L. Slager, James R. Cerhan	7
5	The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL 2021 ·Blood ·Sameer A. Parikh, Kari G. Rabe, Neil E. Kay, Timothy G. Call, Wei Ding, José F. Leis, Saad S. Kenderian, Eli Muchtar, Yucai Wang, Amber B. Koehler, Susan M. Schwager, Connie Lesnick, Geffen Kleinstern, Daniel Van Dyke, Curtis A. Hanson, Esteban Braggio, Susan L. Slager, Tait D. Shanafelt	23
6	The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice 2020 ·Cancer Medicine ·Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call, Kari G. Rabe, Wei Ding, José F. Leis, Saad S. Kenderian, Asher Chanan‐Khan, Amber B. Koehler, Susan M. Schwager, Eli Muchtar, Amie Fonder, Kristen McCullough, (unknown), Matthew D. Smith, Susan L. Slager, Neil E. Kay, Heidi D. Finnes, Tait D. Shanafelt	39
7	Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib 2020 ·Blood Advances ·Paul J. Hampel, (unknown), Timothy G. Call, Wei Ding, Mahsa Khanlari, Ellen D. McPhail, Roberto N. Miranda, Pei Lin, Hussein A. Tawbi, Alessandra Ferrajoli, William G. Wierda, Nitin Jain, Sameer A. Parikh	13
8	Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis 2019 ·Clinical Infectious Diseases ·Angelo Famà, Melissa C. Larson, Brian K. Link, Thomas M. Habermann, Andrew L. Feldman, Timothy G. Call, Stephen M. Ansell, Mark Liebow, Jinhua Xiang, Matthew J. Maurer, Susan L. Slager, Grzegorz S. Nowakowski, Jack T. Stapleton, James R. Cerhan	22
9	Etiologies of Extreme Thrombocytosis: A Contemporary Series 2019 ·Mayo Clinic Proceedings ·Ronan W. Hsieh, Aishwarya Ravindran, C. Christopher Hook, Kebede H. Begna, Aneel A. Ashrani, Rajiv K. Pruthi, Ariela L. Marshall, William J. Hogan, Mark R. Litzow, James D. Hoyer, Jennifer L. Oliveira, Prakash Vishnu, Timothy G. Call, Aref Al‐Kali, Mrinal M. Patnaik, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi, Ronald S. Go	10
10	Human Pegivirus infection and lymphoma risk and prognosis: a North American study 2018 ·British Journal of Haematology ·Angelo Famà, Jinhua Xiang, Brian K. Link, Cristine Allmer, Donna Klinzman, Andrew L. Feldman, Grzegorz S. Nowakowski, Mark Liebow, Melissa C. Larson, Matthew J. Maurer, Stephen M. Ansell, Anne J. Novak, Yan W. Asmann, Susan L. Slager, Timothy G. Call, Thomas M. Habermann, James R. Cerhan, Jack T. Stapleton	20
11	Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication 2014 ·Leukemia & lymphoma ·Deborah A. Bowen, Kari G. Rabe, Susan M. Schwager, Susan L. Slager, Timothy G. Call, David S. Viswanatha, Clive S. Zent	13
12	Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Susan L. Slager, Sara J. Achenbach, Yan W. Asmann, Nicola J. Camp, Kari G. Rabe, Lynn R. Goldin, Timothy G. Call, Tait D. Shanafelt, Neil E. Kay, Julie M. Cunningham, Alice H. Wang, J. Brice Weinberg, Aaron D. Norman, Brian K. Link, José F. Leis, Celine M. Vachon, Mark C. Lanasa, Neil E. Caporaso, Anne J. Novak, James R. Cerhan	12
13	Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma 2012 ·Cancer Causes & Control ·Jennifer L. Kelly, Matthew T. Drake, Zachary S. Fredericksen, Yan W. Asmann, Mark Liebow, Tait D. Shanafelt, Andrew L. Feldman, Stephen M. Ansell, William R. Macon, Megan M. Herr, Alice H. Wang, Grzegorz S. Nowakowski, Timothy G. Call, Thomas M. Habermann, Susan L. Slager, Thomas E. Witzig, James R. Cerhan	35
14	The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender 2012 ·Annals of Epidemiology ·Jennifer L. Kelly, Zachary S. Fredericksen, Mark Liebow, Tait D. Shanafelt, Carrie A. Thompson, Timothy G. Call, Thomas M. Habermann, William R. Macon, Alice H. Wang, Susan L. Slager, James R. Cerhan	16
15	Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Jennifer L. Kelly, Anne J. Novak, Zachary S. Fredericksen, Mark Liebow, Stephen M. Ansell, Ahmet Doǧan, Alice H. Wang, Thomas E. Witzig, Timothy G. Call, Neil E. Kay, Thomas M. Habermann, Susan L. Slager, James R. Cerhan	34
16	Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia 2010 ·Blood ·Tait D. Shanafelt, Matthew T. Drake, Matthew J. Maurer, Cristine Allmer, Kari G. Rabe, Susan L. Slager, George J. Weiner, Timothy G. Call, Brian K. Link, Clive S. Zent, Neil E. Kay, Curtis A. Hanson, Thomas E. Witzig, James R. Cerhan	104
17	CD5‐positive chronic B‐cell lymphoproliferative disorders: Diagnosis and prognosis of a heterogeneous disease entity 2010 ·Cytometry Part B Clinical Cytometry ·Roxana Dronca, Dragan Jevremović, Curtis A. Hanson, Kari G. Rabe, Tait D. Shanafelt, William G. Morice, Timothy G. Call, Neil E. Kay, (unknown), Susan M. Schwager, Susan L. Slager, Clive S. Zent	26
18	Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis 2009 ·Leukemia & lymphoma ·Clive S. Zent, Wei Ding, Megan S. Reinalda, Susan M. Schwager, James D. Hoyer, Deborah A. Bowen, Diane F. Jelinek, Renee C. Tschumper, Timothy G. Call, Tait D. Shanafelt, Neil E. Kay, Susan L. Slager	52
19	Risk of non‐Hodgkin lymphoma in association with germline variation in complement genes 2009 ·British Journal of Haematology ·James R. Cerhan, Anne J. Novak, Zachary S. Fredericksen, Alice H. Wang, Mark Liebow, Timothy G. Call, Ahmet Doǧan, Thomas E. Witzig, Stephen M. Ansell, Thomas M. Habermann, Neil E. Kay, Susan L. Slager	14
20	Views of new internal medicine faculty of their preparedness and competence in physician-patient communication 2006 ·BMC Medical Education ·Paul S. Mueller, Patricia A. Barrier, Timothy G. Call, (unknown), Daniel L. Hurley, (unknown), Jeffrey T. Rabatin, James T.C. Li	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact